Innovating Chronic Disease Management
BioLum Sciences has raised $252K in total funding. The most recent round was Grant. The last funding was announced in December 2021.
BioLum Sciences's investors include National Science Foundation, Bayer, National Institute of General Medical Science.
BioLum Sciences is headquartered in Dallas, United States.
Innovating Chronic Disease Management
BioLum Sciences is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioLum Sciences — Funding & Investors." VCBacked, December 22, 2021, https://www.vcbacked.co/company/biolum-sciences. Accessed September 30, 2026.
VCBacked. (2021). BioLum Sciences — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/biolum-sciences
{{cite web |title=BioLum Sciences — Funding & Investors |url=https://www.vcbacked.co/company/biolum-sciences |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated